Attenuated doses of rituximab for the treatment of adults with autoimmune cytopenias.
D'arena
Giovanni
G
Scalzulli
Potito Rosario
PR
Nobile
Michele
M
Dell'olio
Matteo
M
Rossi
Giovanni
G
Cascavilla
Nicola
N
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001327:Autoimmune Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000188:drug therapy / Q000276:immunology*; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab